Voloridge Investment Management’s AdaptHealth AHCO Stock Holding History

Voloridge Investment Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-236,701	Closed	-$2.25M	–	1152
2024 Q4	$2.25M	Sell	236,701 -135,573	-36%	-$1.37M	0.01%	924
2024 Q3	$4.18M	Buy	372,274 +95,435	+34%	+$1.01M	0.02%	822
2024 Q2	$2.77M	Sell	276,839 -261,478	-49%	-$2.66M	0.01%	891
2024 Q1	$6.2M	Buy	538,317 +290,808	+117%	+$2.47M	0.02%	599
2023 Q4	$1.8M	Buy	247,509 +234,495	+1,802%	+$1.85M	0.01%	851
2023 Q3	$118K	Buy	+13,014	New	+$156K	﹤0.01%	1339
2022 Q4	–	Sell	-109,995	Closed	-$2.07M	–	1409
2022 Q3	$2.07M	Buy	+109,995	New	+$2.26M	0.01%	980
2021 Q4	–	Sell	-31,216	Closed	-$727K	–	1547
2021 Q3	$727K	Buy	+31,216	New	+$755K	﹤0.01%	1367

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Voloridge Investment Management's AHCO Position: Q1 2025 in Review

Voloridge Investment Management sold out of AdaptHealth (AHCO) in Q1 2025, closing a stake of 236,701 shares — an estimated $2.25M sold.

Voloridge Investment Management first reported a position in AHCO in Q3 2021 and held it in 8 quarters. The position peaked at $6.2M in Q1 2024. 226 funds tracked by Wall St. Rank hold AHCO as of Q1 2025.

Voloridge Investment Management reported no remaining AdaptHealth position as of Q1 2025 after selling out during the quarter.
Voloridge Investment Management sold 236,701 AdaptHealth shares in Q1 2025, an estimated $2.25M.
Voloridge Investment Management first reported a position in AdaptHealth in Q3 2021 and held it in 8 quarters.
Voloridge Investment Management's AdaptHealth position peaked at $6.2M in Q1 2024.
226 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2025.

Based on Voloridge Investment Management's 13F filing for Q1 2025, filed 15 May 2025.